Rise Therapeutics Competitors and Similar CompaniesClear all
Rise Therapeutics's competitors and similar companies include ABL Bio, Genelux, Amunix Pharmaceuticals and C4 Therapeutics.
 Rise Therapeutics Rise Therapeutics is a biotech company that develops immunological-based biologics using an oral delivery platform. |  ABL Bio ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease. |  Genelux Genelux is a clinical-stage biopharmaceutical company developing an oncolytic virus-based technology platform. |  Amunix Pharmaceuticals Amunix Pharmaceuticals is a biopharmaceutical company focused on immuno-oncology. |  C4 Therapeutics C4 Therapeutics is a clinical-stage biotechnology company specializing in targeted protein degradation. | |
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 2001 | Founding Date 2006 | Founding Date 2015 |
Type | Type Private | Type Private | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Rockville, US HQ | Locations HQ | Locations Thousand Oaks, US HQ | Locations South San Francisco, US HQ | Locations Watertown, US HQ |
Employees | Employees 196% increase | Employees 615% increase | Employees 157% increase | Employees 42 | Employees 1045% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 106.7 m | Valuation ($) N/A | Valuation ($) 416 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $8k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $35.9m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($32.2m) (FY, 2025) | Net income N/A | Net income ($105m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 200k (over 8 years ago) | Latest funding round $ 65m (almost 8 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 200k | Total funding raised $ 90.8m | Total funding raised N/A | Total funding raised $ 190m | Total funding raised $ 223m |
For sources of this data, please see the company profile
View Company Profiles
ABL Bio
HQ
Employees
61↑ 5% increase
ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.
View companyGenelux
HQ
Thousand Oaks, US
Employees
15↑ 7% increase
Genelux is a clinical-stage biopharmaceutical company developing an oncolytic virus-based technology platform.
View companyAmunix Pharmaceuticals
HQ
South San Francisco, US
Amunix Pharmaceuticals is a biopharmaceutical company focused on immuno-oncology.
View companyC4 Therapeutics
HQ
Watertown, US
Employees
104↓ 5% decrease
C4 Therapeutics is a clinical-stage biotechnology company specializing in targeted protein degradation.
View company